Gastric cancer is one of the most malignant tumors worldwide and remains a major health
threat in Asia-Pacific regions, while its pathological mechanism is generally unknown …

Metabolomics, the systematic investigation of all metabolites present within a biologic
system, is used in biomarker development for many human diseases, including cancer. In …

Recently, there has been increased attention on the analysis of circulating tumor cells (CTC
s), also known as liquid biopsy, owing to its potential benefits in cancer diagnosis and …

Importance Metabolic deregulation plays an important role in gastric cancer (GC)
development. To date, no studies have comprehensively explored the metabolomic profiles …

Objective: Upper gastrointestinal (UGI) cancers, predominantly gastric cancer (GC) and
esophageal cancer (EC), are malignant tumor types with high morbidity and mortality rates …

Background: Metabolomics has shown promise in gastric cancer (GC) detection. This
research sought to identify whether GC has a unique urinary metabolomic profile compared …

Background Mass screening for gastric cancer (GC), particularly using endoscopy, may not
be the most practical approach as a result of its high cost, lack of acceptance, and poor …

As one of the most common malignancies, gastric cancer (GC) is the third leading cause of
cancer-related deaths in China. GC is asymptomatic in early stages, and the majority of GC …

Clinical and animal studies demonstrated that orally administered berberine had a distinct
lipid-lowering effect. However, pharmacokinetic studies showed that berberine was poorly …

Aims This review aims to identify metabolomic biomarkers of oesophago-gastric (OG) cancer
in human biological samples, and to discuss the dominant metabolic pathways associated …